Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Peritoneal Neoplasms × Gynecologic × Clear all

Phase

Status

Sponsor Class

OTHER 132 INDUSTRY 44 NIH 12 OTHER_GOV 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 96 Uterine Cervical Neoplasms 55 Carcinoma, Ovarian Epithelial 54 Fallopian Tube Neoplasms 53 Endometrial Neoplasms 32 Brenner Tumor 18 Sarcoma 14 Vulvar Neoplasms 12 Testicular Neoplasms 11 Squamous Intraepithelial Lesions 10 Sarcoma, Endometrial Stromal 9 Breast Neoplasms 9 Endometrial Adenocarcinoma 8 Precancerous Conditions 7 Sarcoma, Synovial 6 Ovarian Germ Cell Cancer 6 Neurofibrosarcoma 6 Melanoma 6 Liposarcoma 6 Leiomyosarcoma 6 Histiocytoma, Malignant Fibrous 6 Hemangiosarcoma 6 HIV Infections 6 Fibrosarcoma 6 Uterine Cervical Dysplasia 5 Stomach Neoplasms 5 Sarcoma, Alveolar Soft Part 5 Rhabdomyosarcoma 5 Papillomavirus Infections 5 Neuroblastoma 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡